Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8803 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD7819 |
Suspended |
0.8732 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8732 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD1240 |
Approved |
0.8699 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD1549 |
Phase 2 |
0.8662 |
High Similarity |
NPD2796 |
Approved |
0.8609 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8592 |
High Similarity |
NPD1510 |
Phase 2 |
0.8582 |
High Similarity |
NPD1607 |
Approved |
0.8571 |
High Similarity |
NPD2534 |
Approved |
0.8571 |
High Similarity |
NPD2532 |
Approved |
0.8571 |
High Similarity |
NPD2533 |
Approved |
0.8543 |
High Similarity |
NPD1934 |
Approved |
0.8483 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8431 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8403 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8397 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8378 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8377 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8366 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8322 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8267 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8255 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8205 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD6651 |
Approved |
0.817 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8089 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8042 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7949 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7927 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7914 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7867 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7838 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7758 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7758 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7742 |
Intermediate Similarity |
NPD920 |
Approved |
0.773 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7727 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD943 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7679 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.766 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7643 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7635 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7632 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7628 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7626 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7625 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7606 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7603 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD919 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7562 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD411 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7534 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1247 |
Approved |
0.75 |
Intermediate Similarity |
NPD5401 |
Approved |
0.75 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7482 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7412 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7394 |
Intermediate Similarity |
NPD17 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7324 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7315 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.726 |
Intermediate Similarity |
NPD1876 |
Approved |
0.726 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7247 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD1651 |
Approved |
0.72 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3764 |
Approved |
0.72 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7119 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7073 |
Intermediate Similarity |
NPD37 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7051
|
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |